By Bivalirudin is a safer and more effective anticoagulant than heparin for treating patients with the most serious type of heart attacks who undergo urgent percutaneous coronary intervention (PCI), and can lower the risk of death or major bleeding by 31 percent.
Bivalirudin safer, more effective than heparin for treating heart attack patients undergoing coronary intervention
Close Up Scientist using microscope in laboratory room while making medical testing and research
Comments